AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7046034 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ketoprofen per day
Number of subjects: 50
Study 7046034 — intervention group
Group type: COMPARATOR
Intervention: 100 mg indomethacin per day
Number of subjects: 50
Study 30829772 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser applied with an interval of 2 weeks for 7 sessions alongside whole-body nb-UVB phototherapy 3 times a week for at least 4 months.
Number of subjects: 30
Study 30829772 — intervention group
Group type: COMPARATOR
Intervention: Whole-body nb-UVB phototherapy 3 times a week for at least 4 months (control side).
Number of subjects: 30
Study 28583869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar total disc replacement (TDR)
Number of subjects: 173
Study 28583869 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary rehabilitation (MDR)
Number of subjects: 173
Study 26385341 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrosine dose of 220 μM
Number of subjects: 15
Study 26385341 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous irradiation with light for 15 minutes
Number of subjects: 15
Study 26385341 — intervention group
Group type: EXPERIMENTAL
Intervention: Light fractionation of 5 × 1 min irradiation separated by 2-min-dark recovery periods
Number of subjects: 15
Study 26385341 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrosine-based PDT
Number of subjects: 15
Study 26385341 — intervention group
Group type: COMPARATOR
Intervention: Current best practice
Number of subjects: 15
Study 23769763 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 123
Study 23769763 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (sham KT)
Number of subjects: 123
Study 21411243 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotic-release methylphenidate (OROS-MPH)
Number of subjects: 303
Study 21411243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 19690618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone-artesunate (CDA) 2/2.5/4 mg/kg once daily for three days (N = 914)
Number of subjects: 1372
Study 19690618 — intervention group
Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL) six doses over three days (N = 458)
Number of subjects: 1372
Study 16273088 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg/ml plus netilmicin 3 mg/ml (n=148)
Number of subjects: 223
Study 16273088 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 1 mg/ml plus tobramycin 3 mg/ml (n=75, TOBRADEX)
Number of subjects: 223
Study 16273088 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone/netilmicin combination
Number of subjects: 223
Study 15000504 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol group
Number of subjects: 82
Study 15000504 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 82
Study 15000504 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 11283389 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin C (ascorbic acid, AA) levels in ICH and HT patients
Number of subjects: 28
Study 11283389 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin C (ascorbic acid, AA) levels in jugular blood samples
Number of subjects: 28
Study 11283389 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 28
Study 9041214 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed 'variable-sodium' dialysis with dialysate sodium starting at 155 mEq/L and decreasing to 135 mEq/L, held constant at 135 mEq/L for the final half hour.
Number of subjects: 18
Study 9041214 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy with dialysate sodium of 140 mEq/L.
Number of subjects: 18
Study 8179518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE)
Number of subjects: 80
Study 8179518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 3283973 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 100
Study 3283973 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 100
Study 28431408 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Mode (AM) - cycling
Number of subjects: 16
Study 28431408 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Mode (SM) - resistance training
Number of subjects: 16
Study 26061222 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with mCIMT
Number of subjects: 21
Study 26061222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS combined with mCIMT
Number of subjects: 21
Study 26061222 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with mCIMT
Number of subjects: 21
Study 24359312 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal locator device
Number of subjects: 66
Study 24359312 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional fluoroscopy)
Number of subjects: 66
Study 23884332 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental GLA + n-3 PUFAs
Number of subjects: 38
Study 23884332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 20719820 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity task-oriented training
Number of subjects: 44
Study 20719820 — intervention group
Group type: COMPARATOR
Intervention: Low intensity physiotherapy programme
Number of subjects: 44
Study 18627361 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (4 sessions delivered by outpatient obstetrical nurses and research staff)
Number of subjects: 235
Study 18627361 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 235
Study 16154851 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin at a dose of 500 U/kg/week s.c.
Number of subjects: 20
Study 16154851 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 20
Study 12324677 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micro g budesonide
Number of subjects: 28
Study 12324677 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micro g budesonide
Number of subjects: 28
Study 12324677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 10357495 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate zidovudine (AZT) treatment
Number of subjects: 0
Study 10357495 — intervention group
Group type: COMPARATOR
Intervention: Deferred zidovudine (AZT) treatment
Number of subjects: 0
Study 10357495 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of didanosine (ddI)
Number of subjects: 0
Study 10357495 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (AZT)
Number of subjects: 0
Study 8963481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblong levomepromazine tablets
Number of subjects: 12
Study 8963481 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated levomepromazine tablets
Number of subjects: 12
Study 8963481 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion (reference)
Number of subjects: 12
Study 8963481 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 polymorphism analysis
Number of subjects: 12
Study 1903663 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy neutron treatment
Number of subjects: 151
Study 1903663 — intervention group
Group type: COMPARATOR
Intervention: Conventional megavoltage x ray treatment (photon treatment)
Number of subjects: 151
Study 7236081 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 98
Study 7236081 — intervention group
Group type: COMPARATOR
Intervention: Thermosclerostomy
Number of subjects: 98
Study 7236081 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 98
Study 31955835 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% chloramine‐T (CT0.5%)
Number of subjects: 60
Study 31955835 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Ricinus communis (RC10%)
Number of subjects: 60
Study 31955835 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% sodium hypochlorite (SH0.25%)
Number of subjects: 60
Study 31955835 — intervention group
Group type: COMPARATOR
Intervention: Negative control (water)
Number of subjects: 60
Study 31955835 — intervention group
Group type: COMPARATOR
Intervention: Positive control (0.25% sodium hypochlorite)
Number of subjects: 60
Study 31955835 — intervention group
Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 60
Study 28298041 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen, scheduled oral acetaminophen, and rescue opioids
Number of subjects: 62
Study 28298041 — intervention group
Group type: COMPARATOR
Intervention: IV placebo, scheduled oral acetaminophen, and rescue opioids
Number of subjects: 62
Study 27826134 — intervention group
Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=74)
Number of subjects: 120
Study 27826134 — intervention group
Group type: COMPARATOR
Intervention: Standard CTHC (n=46)
Number of subjects: 120
Study 27826134 — intervention group
Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=74) among less educated smokers (n=49)
Number of subjects: 120
Study 27826134 — intervention group
Group type: COMPARATOR
Intervention: Standard CTHC (n=46) among less educated smokers (n=49)
Number of subjects: 120
Study 27826134 — intervention group
Group type: EXPERIMENTAL
Intervention: PERSPeCT (n=55)
Number of subjects: 120
Study 27826134 — intervention group
Group type: COMPARATOR
Intervention: Standard CTHC (n=34)
Number of subjects: 120
Study 24449161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel analysis of PANSS items
Number of subjects: 507
Study 24449161 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA) models
Number of subjects: 507
Study 24449161 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory analysis framework
Number of subjects: 507
Study 23688330 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant-frequency inducer (10 repetitions of a low-frequency pure tone)
Number of subjects: 0
Study 23688330 — intervention group
Group type: COMPARATOR
Intervention: Silence replacing the final inducer tone
Number of subjects: 0
Study 23688330 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant-frequency inducer
Number of subjects: 0
Study 23688330 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant-frequency inducers
Number of subjects: 0
Study 23688330 — intervention group
Group type: EXPERIMENTAL
Intervention: Single deviant (longer tone)
Number of subjects: 0
Study 20025527 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 170
Study 20025527 — intervention group
Group type: COMPARATOR
Intervention: Comparator (vancomycin-aztreonam, imipenem-cilastatin, levofloxacin, vancomycin, or linezolid)
Number of subjects: 170
Study 18421281 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 46
Study 18421281 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction and increased structured exercise (CR+EX)
Number of subjects: 46
Study 18421281 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD)
Number of subjects: 46
Study 18421281 — intervention group
Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 46
Study 16126161 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based cognitive behavioural panic treatment (CBT) (with email contact)
Number of subjects: 55
Study 16126161 — intervention group
Group type: EXPERIMENTAL
Intervention: therapist-assisted CBT manual
Number of subjects: 55
Study 16126161 — intervention group
Group type: COMPARATOR
Intervention: internet-based cognitive behavioural panic treatment (CBT)
Number of subjects: 55
Study 12640069 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 34
Study 12640069 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 34
Study 10763796 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale
Number of subjects: 100
Study 10763796 — intervention group
Group type: COMPARATOR
Intervention: Placebo instrument (Nottingham Instrumental Activities of Daily Living questionnaire)
Number of subjects: 100
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache disorders (lifetime prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache disorders (last year prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache disorders (last week prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache disorders (last 24 hours prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-type headache (last year prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine headache (last year prevalence)
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Last week and last 24 hours headache complaints
Number of subjects: 538
Study 8980856 — intervention group
Group type: EXPERIMENTAL
Intervention: Last year prevalence of headache disorders
Number of subjects: 538
Study 1552466 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline-impregnated fiber only (F)
Number of subjects: 32
Study 1552466 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing with tetracycline-impregnated fiber application (RP/F)
Number of subjects: 32
Study 1552466 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing only (RP)
Number of subjects: 32
Study 1552466 — intervention group
Group type: COMPARATOR
Intervention: Non-treated control (C)
Number of subjects: 32
Study 4056076 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 21
Study 30384767 — intervention group
Group type: EXPERIMENTAL
Intervention: US$2 incentive
Number of subjects: 0
Study 30384767 — intervention group
Group type: EXPERIMENTAL
Intervention: US$5 incentive
Number of subjects: 0
Study 30384767 — intervention group
Group type: EXPERIMENTAL
Intervention: US$10 incentive
Number of subjects: 0
Study 30384767 — intervention group
Group type: COMPARATOR
Intervention: US$0 incentive (control)
Number of subjects: 0
Study 29617523 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan, 200 mg twice daily
Number of subjects: 8399
Study 29617523 — intervention group
Group type: COMPARATOR
Intervention: Enalapril, 10 mg twice daily
Number of subjects: 8399
Study 29617523 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 26721833 — intervention group
Group type: EXPERIMENTAL
Intervention: HRP2/pLDH rapid diagnostic test (RDT) at enrollment
Number of subjects: 540
Study 26721833 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening at enrollment
Number of subjects: 540
Study 26721833 — intervention group
Group type: EXPERIMENTAL
Intervention: RDT negative PCR or microscopy positive infections
Number of subjects: 540
Study 26821227 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (2 mg/day for 2 days)
Number of subjects: 16
Study 26821227 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil (840 mg/day of EPA + DHA for 3 weeks) with Dexamethasone
Number of subjects: 16
Study 22878823 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled catheter drainage (TCD)
Number of subjects: 57
Study 22878823 — intervention group
Group type: COMPARATOR
Intervention: Talc pleurodesis (TP)
Number of subjects: 57
Study 20837192 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine, an anesthetic-analgesic agent, not specified dosage or duration
Number of subjects: 0
Study 18195219 — intervention group
Group type: EXPERIMENTAL
Intervention: hsUHR‐OCT fundus image
Number of subjects: 17
Study 18195219 — intervention group
Group type: EXPERIMENTAL
Intervention: hsUHR‐OCT cross‐sectional image
Number of subjects: 17
Study 18195219 — intervention group
Group type: EXPERIMENTAL
Intervention: geometric disc center location
Number of subjects: 17
Study 16433245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling at 10 p.m. and 8 a.m.
Number of subjects: 0
Study 16433245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling at 9 p.m. and 7 a.m.
Number of subjects: 0
Study 16433245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling at 11 p.m. and 7 a.m.
Number of subjects: 0
Study 16433245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling every 2 hours.
Number of subjects: 0
Study 16433245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling every 3 hours.
Number of subjects: 0
Study 14758407 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and support for management and prevention of STDs
Number of subjects: 14
Study 14758407 — intervention group
Group type: COMPARATOR
Intervention: Control intervention about management of diarrhoea
Number of subjects: 14
Study 10571797 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 50 mg q.d.
Number of subjects: 63
Study 10571797 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 50 mg plus hydrochlorothiazide (HCTZ) 50 mg q.d.
Number of subjects: 63
Study 10571797 — intervention group
Group type: COMPARATOR
Intervention: HCTZ 50 mg q.d.
Number of subjects: 63
Study 10571797 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 63
Study 8927679 — intervention group
Group type: EXPERIMENTAL
Intervention: Low haloperidol plasma level (2 ng/mL)
Number of subjects: 65
Study 8927679 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate haloperidol plasma level (10 ng/mL)
Number of subjects: 65
Study 8927679 — intervention group
Group type: EXPERIMENTAL
Intervention: Low haloperidol plasma level (2 ng/mL) followed by moderate (10 ng/mL)
Number of subjects: 65
Study 8927679 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate haloperidol plasma level (10 ng/mL) followed by low (2 ng/mL)
Number of subjects: 65
Study 1428437 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon gamma (rIFN-gamma)
Number of subjects: 6
Study 3972954 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician interviews
Number of subjects: 0
Study 3972954 — intervention group
Group type: COMPARATOR
Intervention: Self‐administered questionnaires
Number of subjects: 0
Study 3972954 — intervention group
Group type: COMPARATOR
Intervention: Nurse practitioner interviews
Number of subjects: 0
Study 3972954 — intervention group
Group type: COMPARATOR
Intervention: Two physicians' interviews
Number of subjects: 0
Study 3972954 — intervention group
Group type: COMPARATOR
Intervention: Nurse practitioner interview
Number of subjects: 0
Study 30674043 — intervention group
Group type: EXPERIMENTAL
Intervention: ADVAGOshoulder orthesis
Number of subjects: 53
Study 30674043 — intervention group
Group type: COMPARATOR
Intervention: standard abduction orthesis
Number of subjects: 53
Study 30054227 — intervention group
Group type: EXPERIMENTAL
Intervention: YESHealth intervention (quarterly reports plus baseline PDQ-S results)
Number of subjects: 720
Study 30054227 — intervention group
Group type: COMPARATOR
Intervention: PDQ-S results only
Number of subjects: 720
Study 30054227 — intervention group
Group type: COMPARATOR
Intervention: No study information
Number of subjects: 720
Study 26985729 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) alone for 15 sessions
Number of subjects: 85
Study 26985729 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) followed by Cognitive-Behavioral Therapy (CBT) integrated with MI (4 MI sessions + 11 CBT sessions)
Number of subjects: 85
Study 25318780 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-guided practice
Number of subjects: 0
Study 25318780 — intervention group
Group type: COMPARATOR
Intervention: Unassisted training
Number of subjects: 0
Study 20473737 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine therapy (Kunbao Pill and Modified Xiaoyao Pill)
Number of subjects: 185
Study 20473737 — intervention group
Group type: COMPARATOR
Intervention: Psychological intervention alone
Number of subjects: 185
Study 20473737 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Chinese medicine therapy + psychological intervention)
Number of subjects: 185
Study 15703770 — intervention group
Group type: EXPERIMENTAL
Intervention: IC-PGE1 + 50 mg sildenafil
Number of subjects: 40
Study 15703770 — intervention group
Group type: COMPARATOR
Intervention: IC-PGE1-placebo
Number of subjects: 40
Study 15703770 — intervention group
Group type: COMPARATOR
Intervention: 50 mg sildenafil
Number of subjects: 40
Study 15703770 — intervention group
Group type: COMPARATOR
Intervention: 100 mg sildenafil
Number of subjects: 40
Study 11925053 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelve Step Facilitation
Number of subjects: 952
Study 11925053 — intervention group
Group type: COMPARATOR
Intervention: Motivational Enhancement Therapy
Number of subjects: 952
Study 11925053 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 952
Study 9389394 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal sutures
Number of subjects: 242
Study 9389394 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 242
Study 7874150 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (swimmers)
Number of subjects: 18
Study 7874150 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic exercise (wrestlers)
Number of subjects: 18
Study 7874150 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 18
Study 3061557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 110
Study 3061557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 11391690 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term survivor mixture model with random effects
Number of subjects: 0
Study 11391690 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized linear mixed model (GLMM) approach
Number of subjects: 0
Study 31564523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 31564523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30087427 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose PORT (>66.60 cGy)
Number of subjects: 0
Study 30087427 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high dose PORT (>70.20 cGy)
Number of subjects: 0